{"id":4902,"date":"2025-10-02T10:20:55","date_gmt":"2025-10-02T00:20:55","guid":{"rendered":"\/eu-uk\/?p=4902"},"modified":"2025-10-02T10:25:11","modified_gmt":"2025-10-02T00:25:11","slug":"orthocell-announces-record-revenue-of-3m-for-september-quarter","status":"publish","type":"post","link":"\/eu-uk\/blog\/2025\/10\/02\/orthocell-announces-record-revenue-of-3m-for-september-quarter\/","title":{"rendered":"Orthocell Announces Record Revenue of $3m for September Quarter"},"content":{"rendered":"<p><span data-contrast=\"auto\">Orthocell has announced record quarterly revenue of $3.0 million for the September quarter \u2013 our sixth consecutive quarter of record revenue growth.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">This outstanding 9.1% increase reflects the strong market uptake of Remplir\u2122 in Australia and Singapore, with the US rollout now gaining momentum and Canada coming online in the December quarter.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\">Key Highlights:<\/span><\/b><\/p>\n<ul>\n<li><span data-contrast=\"auto\">Record quarterly revenue of $3.0m (up 9.1% from June quarter)<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Sixth consecutive quarter of record revenue<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">CQGR of 9.5% since Q2 FY23 launch<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">~$27.0m cash and no debt<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">US rollout accelerating with &gt;100 surgeons introduced &amp; 11 hospital approvals secured<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">First Canadian distributor appointed \u2013 initial sales targeted for December quarter<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Orthocell CEO &amp; MD, Paul Anderson, said:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p data-ccp-border-between=\"0px none #000000\" data-ccp-padding-between=\"0px\"><i><span data-contrast=\"none\">\u201cThe record revenue result for the September quarter is a particularly pleasing result, given it has largely been achieved from our existing markets in Australia and Singapore.\u00a0 It\u2019s a tangible confirmation that surgeons are growing increasingly comfortable using Remplir in nerve repair procedures.\u201d<\/span><\/i><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:240,&quot;335572071&quot;:0,&quot;335572072&quot;:0,&quot;335572073&quot;:0,&quot;335572075&quot;:0,&quot;335572076&quot;:0,&quot;335572077&quot;:0,&quot;335572079&quot;:0,&quot;335572080&quot;:0,&quot;335572081&quot;:0,&quot;335572083&quot;:0,&quot;335572084&quot;:0,&quot;335572085&quot;:0,&quot;335572087&quot;:0,&quot;335572088&quot;:0,&quot;335572089&quot;:0,&quot;469789798&quot;:&quot;nil&quot;,&quot;469789802&quot;:&quot;nil&quot;,&quot;469789806&quot;:&quot;nil&quot;,&quot;469789810&quot;:&quot;nil&quot;,&quot;469789814&quot;:&quot;nil&quot;}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/announcements.asx.com.au\/asxpdf\/20251002\/pdf\/06q0qj8frgrhb4.pdf\"><span data-contrast=\"auto\">Click to read today\u2019s ASX release.<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has announced record quarterly revenue of $3.0 million for the September quarter \u2013 our sixth consecutive quarter of record revenue growth. <\/p>\n","protected":false},"author":2,"featured_media":4906,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4902"}],"version-history":[{"count":2,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4902\/revisions"}],"predecessor-version":[{"id":4905,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4902\/revisions\/4905"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4906"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4902"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}